These data are consistent with the proteasome-mediated degradation of activated IRF3 during virus infection (in order to prevent continuous activation of the IFN-β promoter) by a mechanism that requires ongoing protein synthesis (Lin et al., 1998; Ye & Maniatis, 2011). This evidence concerns the gene IFNB1 and viral infectious disease.